.png){kind=icon}
.png){kind=icon}
Return
A pilot randomized feasibility clinical trial of intranasal vs. intravenous naloxone in pediatric opioid poisoning
.png){kind=icon}
OA
AI
N
A
F
N
A
R
H
DOI：10.1016/j.drugalcdep.2026.113259.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Intranasal naloxone was as feasible as intravenous naloxone in pediatric opioid poisoning. • Intranasal naloxone offers a practical alternative where intravenous access is delayed or unavailable. • Early intranasal administration may prevent treatment delays caused by intravenous catheter insertion.
Keywords:
Naloxone
Intranasal
Intravenous
Pediatric
Opioid
Overdose
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.6
Papers:
1.2W
Citations:
2.4W
Organization
Cited Papers